Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The synthetic cannabinoids menace: a review of health risks and toxicity
Ayman Alzu’bi, Fatimah Almahasneh, Ramada R. Khasawneh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Delineating the Molecular Mechanisms of Hippocampal Neurotoxicity Induced by Chronic Administration of Synthetic Cannabinoid AB-FUBINACA in Mice
Ayman Alzu’bi, Ejlal Abu‐El‐Rub, Fatimah Almahasneh, et al.
NeuroToxicology (2024) Vol. 103, pp. 50-59
Open Access | Times Cited: 6
NMR Spectroscopic Reference Data of Synthetic Cannabinoids Sold on the Internet
Eva‐Maria Hubner, Martin G. Schmid, Verina Manojlović, et al.
Magnetic Resonance in Chemistry (2025) Vol. 63, Iss. 3, pp. 241-255
Open Access
The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
Synthetic Cannabinoids in Sierra Leone: Understanding the Use of ‘Kush’ Among Youths and Its Socioeconomic Impact in Sierra Leone and Sub‐Region
Michael Lahai, Ahmed Vandy, Alvin Turay, et al.
Public Health Challenges (2025) Vol. 4, Iss. 1
Open Access
Clinical and Public Health Challenge of Handling Synthetic Cathinone and Cannabinoid Abuse in Pediatric Care: A Narrative Review
Valerio Ricci, Giuseppe Maina
Pediatric Reports (2025) Vol. 17, Iss. 1, pp. 19-19
Open Access
Synthetic Cannabinoid Use Among Noninstitutionalized Individuals in the United States, 2021-2023
Joseph J. Palamar, Nina Abukahok, Austin Le
Drug and Alcohol Dependence (2025) Vol. 270, pp. 112603-112603
Closed Access
Hippocampal Apoptosis: Molecular Mechanisms Triggered by Toxic Cannabinoid Exposure: A Narrative Review
Habibeh Mashayekhi‐Sardoo, Mahdiyeh Hedayati-Moghadam, Yousef Baghcheghi
NeuroToxicology (2025)
Closed Access
New Insights Into the Neural Consequences of Synthetic Cannabinoids During Adolescence: The Critical Role of Reelin at Prefrontal Synapses
G. M. Prosperi, Antonia Manduca
Biological Psychiatry Global Open Science (2025) Vol. 5, Iss. 2, pp. 100456-100456
Open Access
ADB-FUBINACA-induced developmental toxicity, neurotoxicity, and cardiotoxicity in embryonic zebrafish (Danio rerio)
Yuanzhao Wu, Fenliang Fan, Lu Zhou, et al.
Environmental Research (2025), pp. 121517-121517
Closed Access
Fast and ecologic SUPRAS extraction and UPLC–MS/MS analysis for 13 synthetic cannabinoids in hair and wastewater
Zhihui Chen, Zhen‐Yu Zhang, Jianwen Zhou, et al.
Microchemical Journal (2025), pp. 113557-113557
Closed Access
Does a postmortem redistribution affect the concentrations of the 7 azaindole-derived synthetic cannabinoid 5F-MDMB-P7AICA in tissues and body fluids following pulmonary administration to pigs?
Adrian A. Doerr, Frederike Nordmeier, Nadja Walle, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 10, pp. 3289-3298
Open Access | Times Cited: 2
Hazardous Materials from Threats to Safety: Molecularly Imprinted Polymers as Versatile Safeguarding Platforms
Ana-Mihaela Gavrilă, Aurel Diacon, Tanţa-Verona Iordache, et al.
Polymers (2024) Vol. 16, Iss. 19, pp. 2699-2699
Open Access | Times Cited: 1
Cannabis flower, concentrates, and edibles: a narrative review comparing prevalence of use, methods of consumption, and cannabis use disorder outcomes
Arpana G. Inman, Anita Cservenka
Journal of Addictive Diseases (2024), pp. 1-11
Closed Access | Times Cited: 1
Navigating Parenting Challenges
Ranjit Singha
Advances in early childhood and K-12 education (2024), pp. 315-335
Closed Access
In vivo assessment of the nephrotoxic effects of the synthetic cannabinoid AB-FUBINACA
Ayman Alzu’bi, Ejlal Abu‐El‐Rub, Bahaa Al‐Trad, et al.
Forensic Toxicology (2024)
Open Access
Prevalence and Trends of Suspected Cannabinoid Hyperemesis Syndrome Over an 11-Year Period in Northern California: An Electronic Health Record Study
Brianna Costales, Yun Lu, Kelly C. Young‐Wolff, et al.
Drug and Alcohol Dependence (2024) Vol. 263, pp. 112418-112418
Closed Access
Cannabinoids in the Inflamed Synovium Can Be a Target for the Treatment of Rheumatic Diseases
Livia Roseti, Giorgia Borciani, Emanuela Amore, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9356-9356
Open Access
Cannabis Use Variations and Myocardial Infarction: A Systematic Review
Jan van Amsterdam, Wim van den Brink
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5620-5620
Open Access
Psychiatric problems in medical patients relevant to primary care physicians and mental health providers
Harold G. Koenig
The International Journal of Psychiatry in Medicine (2024)
Closed Access
Effects of MDA‐19 on Zebrafish Larval Behavior: Perspectives From Neurodevelopment, Oxidative Stress, and Metabolomics
Boyang Xu, Jun Yan, Yangtao Zhou, et al.
Journal of Applied Toxicology (2024)
Open Access
Third-Generation Therapies for the Management of Psychoactive Substance Use in Young People: Scoping Review
Gabriela Sequeda, Johan E. Acosta-López, Édgar Díaz-Camargo, et al.
Behavioral Sciences (2024) Vol. 14, Iss. 12, pp. 1192-1192
Open Access
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation
Ewelina Młynarska, Natalia Kustosik, Maja Mejza, et al.
Nutrients (2024) Vol. 17, Iss. 1, pp. 59-59
Open Access
Page 1

Scroll to top